Blog
Investing in Microchip Tech (MCHP)? Don't Miss Assessing Its International Revenue Trends
Have you assessed how the international operations of Microchip Technology (MCHP) performed in the quarter ended June 2025? For this chipmaker, possessing an expansive global footprint, parsing the
Don't Overlook Uber (UBER) International Revenue Trends While Assessing the Stock
Have you looked into how Uber Technologies (UBER) performed internationally during the quarter ending June 2025? Considering the widespread global presence of this ride-hailing company, examining
Lilly (LLY) Reliance on International Sales: What Investors Need to Know
Did you analyze how Eli Lilly (LLY) fared in its international operations for the quarter ending June 2025? Given the widespread global presence of this drugmaker, scrutinizing the trends in
Why IPG (IPGP) International Revenue Trends Deserve Your Attention
Have you evaluated the performance of IPG Photonics' (IPGP) international operations for the quarter ending June 2025? Given the extensive global presence of this high-powered laser maker
Applied Industrial Technologies (AIT) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Wall Street analysts expect Applied Industrial Technologies (AIT) to post quarterly earnings of $2.60 per share in its upcoming report, which indicates a year-over-year decline of 1.5%. Revenues
International Markets and Capri Holdings (CPRI): A Deep Dive for Investors
Have you evaluated the performance of Capri Holdings' (CPRI) international operations during the quarter that concluded in June 2025? Considering the extensive worldwide presence of this luxury
Why KLA (KLAC) International Revenue Trends Deserve Your Attention
Have you assessed how the international operations of KLA (KLAC) performed in the quarter ended June 2025? For this maker of equipment for manufacturing semiconductors, possessing an expansive
Why Teradyne (TER) International Revenue Trends Deserve Your Attention
Have you evaluated the performance of Teradyne's (TER) international operations for the quarter ending June 2025? Given the extensive global presence of this maker of wireless products, data
Understanding Steris (STE) Reliance on International Revenue
Have you looked into how Steris (STE) performed internationally during the quarter ending June 2025? Considering the widespread global presence of this medical products maker, examining the trends
Staar Surgical (STAA) International Revenue in Focus: Trends and Expectations
Have you looked into how Staar Surgical (STAA) performed internationally during the quarter ending June 2025? Considering the widespread global presence of this maker of implantable lenses
Unveiling Amcor (AMCR) Q4 Outlook: Wall Street Estimates for Key Metrics
The upcoming report from Amcor (AMCR) is expected to reveal quarterly earnings of $0.21 per share, indicating no change from the year-ago quarter. Analysts forecast revenues of $5.17 billion
Stay Ahead of the Game With Tapestry (TPR) Q4 Earnings: Wall Street's Insights on Key Metrics
In its upcoming report, Tapestry (TPR) is predicted by Wall Street analysts to post quarterly earnings of $1.00 per share, reflecting an increase of 8.7% compared to the same period last year
Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock
Did you analyze how Insmed (INSM) fared in its international operations for the quarter ending June 2025? Given the widespread global presence of this biopharmaceutical developing inhaled treatments
Curious about Deere (DE) Q3 Performance? Explore Wall Street Estimates for Key Metrics
In its upcoming report, Deere (DE) is predicted by Wall Street analysts to post quarterly earnings of $4.62 per share, reflecting a decline of 26.6% compared to the same period last year. Revenues
Unlocking Q2 Potential of Nice (NICE): Exploring Wall Street Estimates for Key Metrics
Analysts on Wall Street project that Nice (NICE) will announce quarterly earnings of $2.99 per share in its forthcoming report, representing an increase of 13.3% year over year. Revenues are
International Flavors (IFF) Reliance on International Sales: What Investors Need to Know
Have you looked into how International Flavors (IFF) performed internationally during the quarter ending June 2025? Considering the widespread global presence of this ingredients producer for food
Insights Into Applied Materials (AMAT) Q3: Wall Street Projections for Key Metrics
The upcoming report from Applied Materials (AMAT) is expected to reveal quarterly earnings of $2.34 per share, indicating an increase of 10.4% compared to the year-ago period. Analysts forecast
Unlocking Q2 Potential of Advance Auto Parts (AAP): Exploring Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Advance Auto Parts (AAP) will report quarterly earnings of $0.59 per share in its upcoming release, pointing to a year-over-year decline of 21.3%. It is
APA Q2 Earnings Shine With Beat on Both Top and Bottom Lines
U.S. energy operator APA Corporation APA reported second-quarter 2025 adjusted earnings of 87 cents per share, beating the Zacks Consensus Estimate of 45 cents. The outperformance primarily reflects
Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results?
Pfizer (PFE) announced strong second-quarter 2025 results on Aug. 5, beating estimates for both earnings and sales. Adjusted EPS of 78 cents rose 30% year over year while revenues of $14.7 billion
3 Top Dividend Stocks to Maximize Your Retirement Income
Believe it or not, seniors fear running out of cash more than they fear dying.
And retirees have good reason to be worried about making their assets last. People are living longer, so that money has
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
Here's a revealing data point: older Americans are scared more of outliving wealth than of death itself.
And unfortunately, even retirees who have built a nest egg have good reason to be
Salesforce Stock Plunges 28% YTD: Should You Exit the Investment?
Salesforce, Inc. CRM is having one of its worst years in recent memory. The stock has declined 28% in 2025, a steeper fall than the 13.5% drop in the broader Zacks Computer and Technology sector.
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
As we near the end of the ongoing earnings season, the scorecard for the Medical sector appears pretty decent. The sector primarily comprises pharma/biotech and medical device companies. Almost all



